fiscal
year
calendar
months
ended
ended
year
1996
thousands
dec
31
dec
31
jun
30
proforma
1996
1995
1996
unaudited
share
amounts
unaudited
total
revenues
2,111
1,647
3,867
4,331
net
income
loss
353
180
119
54
net
income
loss
common
share
08
06
03
01
average
shares
outstanding
4,192
3,221
4,298
3,707full
nastech
pharmaceutical
company
